Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells

Blood Advances 2026 Open access

Read full text
Authors: Dominic Pizzarella, Amanda Kofides, John M. Hatcher, Xia Liu, Alberto Güijosa, Nickolas Tsakmaklis, Abigail Peachey, Jinhua Wang, Maria Luisa Guerrera, Christopher J. Patterson, Zachary R. Hunter, Hao Sun
+7 more Shayna Sarosiek, Jorge J. Castillo, Sara Buhrlage, Sirano Dhe‐Paganon, Andrew Robert Branagan, Steven Peter Treon, Shirong Liu
DOI: 10.1182/bloodadvances.2025018126
Cited by: 1
References: 23

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Myeloproliferative Neoplasms: Diagnosis and Treatment Chronic Myeloid Leukemia Treatments

Publication details

Journal / source
Blood Advances
Publisher
American Society of Hematology
Volume
10
Issue
13
Pages
4450–4454
Publication date
15 April 2026
Language
EN